Kavallaris M - Search Results

1

MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors.

Kavallaris M, Leary JA, Barrett JA, Friedlander ML. Kavallaris M, et al. Cancer Lett. 1996 Apr 19;102(1-2):7-16. doi: 10.1016/0304-3835(96)04143-2. Cancer Lett. 1996. PMID: 8603381

2

When polymers meet carbon nanostructures: expanding horizons in cancer therapy.

Cirillo G, Peitzsch C, Vittorio O, Curcio M, Farfalla A, Voli F, Dubrovska A, Iemma F, Kavallaris M, Hampel S. Cirillo G, et al. Among authors: kavallaris m. Future Med Chem. 2019 Aug;11(16):2205-2231. doi: 10.4155/fmc-2018-0540. Future Med Chem. 2019. PMID: 31538523 Review.

3

Association of N-myc amplification with neuroblastoma: the Australian and New Zealand experience.

Telford DJ, Kavallaris M, White L, Norris MD, Brian MJ, Stewart BW. Telford DJ, et al. Among authors: kavallaris m. J Paediatr Child Health. 1992 Feb;28(1):58-63. doi: 10.1111/j.1440-1754.1992.tb02619.x. J Paediatr Child Health. 1992. PMID: 1554517

4

Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T-cell leukemia xenograft, LALW-2.

Norris MD, Haber M, Kavallaris M, Brian MJ, Lutze LH, White L, Stewart BW. Norris MD, et al. Among authors: kavallaris m. Cancer. 1991 Sep 1;68(5):981-7. doi: 10.1002/1097-0142(19910901)68:5<981::aid-cncr2820680512>3.0.co;2-w. Cancer. 1991. PMID: 1913492

5

Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.

Kavallaris M, Haber M, Norris MD, Pittman SM, Reed C, Stewart BW. Kavallaris M, et al. Cancer Lett. 1990 Jun 15;51(3):193-201. doi: 10.1016/0304-3835(90)90102-4. Cancer Lett. 1990. PMID: 1972035

6

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW. Haber M, et al. Among authors: kavallaris m. Cancer Res. 1989 Oct 1;49(19):5281-7. Cancer Res. 1989. PMID: 2569932

7

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW. Haber M, et al. Among authors: kavallaris m. J Natl Cancer Inst. 1989 Aug 16;81(16):1250-4. doi: 10.1093/jnci/81.16.1250. J Natl Cancer Inst. 1989. PMID: 2754745

8

An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro.

Haber M, Norris MD, Kavallaris M, Camacho M, Madafiglio J, Baker CJ, White L, Stewart BW. Haber M, et al. Among authors: kavallaris m. Cancer Lett. 1995 Oct 20;97(1):49-55. doi: 10.1016/0304-3835(95)03950-2. Cancer Lett. 1995. PMID: 7585477

9

N-myc gene amplification in neuroblastoma determined by the polymerase chain reaction.

Norris MD, Haber M, Gilbert J, Kavallaris M, Marshall GM, Stewart BW. Norris MD, et al. Among authors: kavallaris m. Prog Clin Biol Res. 1994;385:27-33. Prog Clin Biol Res. 1994. PMID: 7972220 No abstract available.

10

Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.

Kavallaris M, Madafiglio J, Norris MD, Haber M. Kavallaris M, et al. Biochem Biophys Res Commun. 1993 Jan 15;190(1):79-85. doi: 10.1006/bbrc.1993.1013. Biochem Biophys Res Commun. 1993. PMID: 8093660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results